News Search Results
Jan 28, 2025, 10:35 ET Hevolution Foundation Hosting Over 2,000 International Experts at the Second Global Healthspan Summit to Explore Ways to Extend Healthy Years of Life
Seasons Hotel brings together international attendees, including world leaders, policymakers, researchers & scientists, and experts from the biotechnology, pharmaceutical, healthcare, and private sectors, to explore innovative solutions in the rapidly advancing fields of geroscience and healthspan.
More news about: Hevolution Foundation
Jan 28, 2025, 10:01 ET Next-generation Sequencing (NGS) Market to Hit USD 22.38 Billion by 2029 with 11.0% CAGR | MarketsandMarkets™
segment. Based on services end users, the NGS services market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, hospitals & clinical laboratories, and other end users. In 2023, the academic & research laboratories segment accounted for the
More news about: MarketsandMarkets
Jan 28, 2025, 09:34 ET miRecule and GBI Biomanufacturing Announce Strategic Partnership to Advance Development of Antibody RNA Conjugate (ARC) Therapies
miRecule, a biotechnology company pioneering RNA therapies, and
More news about: GBI Biomanufacturing
Jan 28, 2025, 09:00 ET Debut Unveils AI-powered Ingredient Discovery Platform to Fuel Biotech Innovation for All Beauty Brands Globally through Partner KDC/one
https://www.prnewswire.com/news-releases/debut-unveils-ai-powered-ingredient-discovery-platform-to-fuel-biotech-innovation-for-all-beauty-brands-globally-through-partner-kdcone-302361403.html SOURCE Debut Biotechnology
More news about: Debut Biotechnology
Jan 28, 2025, 08:00 ET Drug Monitoring Committee Authorizes Continuation of Intensity Therapeutics' Ongoing Global Randomized Phase 3 Sarcoma Trial ("INVINCIBLE-3 Study") Following Periodic Review
Intensity Therapeutics, Inc. (Nasdaq: INTS), ("Intensity" or "the Company") a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies designed to kill tumors and increase
More news about: Intensity Therapeutics Inc.
Jan 28, 2025, 07:30 ET Palatin Provides Update on Anticipated 2025 Corporate Milestones
complete clinical trials and submit applications for regulatory approvals, products developed by competing pharmaceutical, biopharmaceutical and biotechnology companies, commercial acceptance of Palatin's products, and other factors discussed in Palatin's periodic filings with the Securities and Exchange
More news about: Palatin Technologies, Inc.
Jan 28, 2025, 07:20 ET EQT Life Sciences leads USD 75 million Series B in Atalanta Therapeutics, a biotech firm developing treatments for epilepsy and Huntington's disease
has led a USD 75 million Series B funding round in Atalanta Therapeutics ("Atalanta" or "the Company"). Atalanta, a biotechnology company based in Boston, USA, is at the forefront of using RNA interference (RNAi)
More news about: EQT
Jan 28, 2025, 07:00 ET Origin Agritech to Hold Business Update & Fiscal Year 2024 Earnings Conference Call on Tuesday, February 11th at 8 a.m. ET
the Bio-Safety Certificate from China's Ministry of Agriculture. Over the years, Origin has established a robust biotechnology seed pipeline, including products with glyphosate tolerance and pest resistance (Bt) traits. For further information, please visit the Company's
More news about: Origin Agritech Limited
Jan 28, 2025, 07:00 ET Leap Therapeutics Reports Initial Clinical Data from Part B of the DeFianCe Study and Part C of the DisTinGuish Study
Mass., Jan. 28, 2025 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced positive initial data from Part B of the DeFianCe study
More news about: Leap Therapeutics, Inc.
Jan 28, 2025, 06:17 ET Chandigarh University Lucknow gets UGC nod; To kick start admissions in 43 AI Augmented programs for 2025 session
When it comes to Health and Life Sciences, Chandigarh University Lucknow is offering seven undergraduate courses including Bachelor of Science (Biotechnology), B Sc. Forensic Science, Bachelor of Pharmacy (B Pharma), Bachelor of Optometry, B Sc. - Medical Laboratory Technology (MLT), Bachelor of Physiotherapy
More news about: Chandigarh University Lucknow
Jan 27, 2025, 18:07 ET Anivive Secures $20 Million Investment from Leonid Capital Partners to Develop the Next Generation of Pet Health
other emerging illnesses. About Anivive Lifesciences Anivive Lifesciences is a pet pharmaceutical company at the forefront of biotechnology, artificial intelligence, and veterinary medicine. Our mission is to transform veterinary healthcare by accelerating the development of novel, affordable
More news about: Anivive Lifesciences Inc.
Jan 27, 2025, 11:00 ET ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research.
TOKYO, Jan. 27, 2025 /PRNewswire/ -- ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, announced today that it will begin the pre-commercial
More news about: ThinkCyte Inc.
Jan 27, 2025, 11:00 ET ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research.
TOKYO, Jan. 27, 2025 /PRNewswire/ -- ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, announced today that it will begin the pre-commercial
More news about: ThinkCyte Inc.
Jan 27, 2025, 09:26 ET Advanced Instruments Releases the OsmoPRO® MAX Automated Osmometer to Enhance Clinical Lab Productivity
years." About Advanced Instruments Advanced Instruments, LLC, is a leading supplier of instrumentation for clinical, pharmaceutical, biotechnology, microbiology, and food laboratories around the world. Quality, reliability, service and support have been the company's guiding principles since
More news about: Advanced Instruments
Jan 27, 2025, 09:19 ET Advanced Instruments Releases the OsmoPRO® MAX Automated Osmometer to Enhance Clinical Lab Productivity
years." About Advanced Instruments Advanced Instruments, LLC, is a leading supplier of instrumentation for clinical, pharmaceutical, biotechnology, microbiology, and food laboratories around the world. Quality, reliability, service and support have been the company's guiding principles since
More news about: Advanced Instruments
Jan 27, 2025, 09:00 ET JPA Health Launches Investor Relations Practice, Expanding Suite of Services Across Life Sciences
Health, an award-winning health innovation agency, is proud to announce the launch of its Investor Relations (IR) practice, offering pharmaceutical, biotechnology, and medical device clients the ability to build stronger connections with IR audiences. Supported by the agency's expertise in data analytics and
More news about: JPA Health
Jan 27, 2025, 08:56 ET Inflectra Earns AWS Competencies in Life Sciences and Education, Cementing Leadership Across Regulated and Collaborative Sectors
Driving Regulatory Excellence Inflectra's AWS Life Sciences Competency showcases Spira's ability to empower pharmaceutical companies, biotechnology firms, and medical device manufacturers to navigate the stringent regulatory environment while accelerating innovation. Key benefits for
More news about: Inflectra
Jan 27, 2025, 08:00 ET Sapience Therapeutics Presents ST316 Phase 1 Dose Escalation Data at the 2025 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium
Jan. 27, 2025 /PRNewswire/ -- Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address oncogenic and immune dysregulation that drive cancer, today
More news about: Sapience Therapeutics, Inc.
Jan 27, 2025, 08:00 ET Dalan Animal Health Taps Dr. Erin Strait to Drive Next Wave of Innovation as Chief Scientific Officer
Ga., Jan. 27, 2025 /PRNewswire/ -- Dalan Animal Health, a pioneering biotechnology company developing vaccines that leverage innate immunity, announced today the appointment of Erin Strait, DVM, Ph.D.,
More news about: Dalan Animal Health, Inc.
Jan 27, 2025, 07:45 ET Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
Jan. 27, 2025 /PRNewswire/ -- Averna Therapeutics, Inc. ("Averna"; formerly known as Exsilio Therapeutics, Inc.), a biotechnology company developing genomic medicines that insert therapeutic changes into the genome, today announced the appointment of Thomas
More news about: Averna Therapeutics
Jan 26, 2025, 18:30 ET FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease
LinkedIn.About Biogen Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients' lives and to create value for shareholders and our communities.
More news about: Eisai Inc.
Jan 24, 2025, 09:55 ET Curiox Biosystems Launches Curiox C- Free Pluto ALPHA: Affordable, Hassle-Free Cell Washing Automation
contact us for more information. About Curiox Biosystems Co. Ltd Curiox Biosystems Co. Ltd is a rapidly growing global biotechnology company specializing in advanced sample preparation solutions that enhance next-generation therapies. The company leverages expertise in surface
More news about: Curiox Biosystems
Jan 24, 2025, 09:00 ET Nuevocor Welcomes Andreas Wallnöfer as Chairman of the Board of Directors
Jan. 24, 2025 /PRNewswire/ -- Nuevocor, an IND-stage biotechnology company dedicated to developing functional cures to treat cardiomyopathies with aberrant mechanobiology, today announces the appointment of Dr.
More news about: Nuevocor
Jan 24, 2025, 03:44 ET BPC announces Directed Share Issue to Eiffel Investment Group
deliver sustainable growth." Background and reasons BPC develops solutions that advance renewable energy and environmental biotechnology. With a strong foundation of expertise, BPC delivers technologies and services that improve energy extraction and resource management. Eiffel Investment
More news about: BPC Instruments AB
Jan 24, 2025, 01:59 ET Kexing Biopharm Participates in the 17th Biotech Showcase, with Multiple Innovation Pipelines Gaining Attention
investors in the biotechnology and pharmaceutical sectors, providing an opportunity to gain insight into the latest industry trends. The Biotech Showcase brings more than 400 selected global companies together, covering diverse fields such as innovative biopharmaceuticals, biotechnology platforms, digital
More news about: Kexing Biopharm